or Try an Advanced Search...

    Clinical Trial Products Stocks List

    Symbol Grade Name % Change
    INCY D Incyte Corporation 0.42
    BIIB C Biogen Idec Inc. 0.23
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Clinical Trial Product Nasdaq 100 Psoriasis S&P 500 Alzheimer's Disease Autoimmune Disorders Biopharmaceutical Biotechnology Cd20 Chemical Compounds Chronic Lymphocytic Leukemia Degenerative Disease Diabetic Nephropathy Disability Hematologic Malignancies Hemophilia Idiopathic Pulmonary Fibrosis Immune Disorders Immunology Immunosuppressants

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Products stocks.

    Symbol Grade Name Weight
    BIS D ProShares UltraShort Nasdaq Biotechnology 8.21
    FBT D First Trust Amex Biotech Index Fund 6.96
    BBH C Market Vectors Biotech ETF 6.31
    PBE C PowerShares Dynamic Biotech & Genome 5.07
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 4.87
    View all Clinical Trial Products ETFs...
    Compare ETFs
    Compare BIS to FBT Compare BIS to PBE Compare PBE to FTXH

        Clinical Trial Products Stocks Recent News

        Date Stock Title
        May 17 BIIB Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 INCY Here's Why Incyte (INCY) Stock is Up More Than 7% in a Week
        May 17 BIIB Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
        May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
        May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
        May 15 BIIB Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
        May 15 BIIB Eisai sets new revenue target for Alzheimer’s drug Leqembi
        May 15 BIIB Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy
        May 15 BIIB UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 BIIB Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
        May 14 BIIB Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 INCY Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress
        May 14 INCY Company News For May 14, 2024
        May 14 INCY Heard on the Street Monday Recap: Hello Kitty
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Clinical Trial Product Nasdaq 100 Psoriasis S&P 500 Alzheimer's Disease Autoimmune Disorders Biopharmaceutical Biotechnology Cd20 Chemical Compounds Chronic Lymphocytic Leukemia Degenerative Disease Diabetic Nephropathy Disability Hematologic Malignancies Hemophilia Idiopathic Pulmonary Fibrosis Immune Disorders Immunology Immunosuppressants
        Clinical Trial Products

        Clinical trial products are any products used in clinical trials, such as drugs, medical devices, or biologics. These products are tested in clinical trials to determine their safety and efficacy for treating a particular medical condition. Clinical trial products must meet strict regulatory requirements before they can be approved for use in humans.

        Browse All Tags